“CemiplimAb-Rwlc Survivorship and Epidemiology (CASE): A Prospective Study of the Safety and Efficacy of Cemiplimab in Patients With Advanced Cutaneous Squamous Cell Carcinoma (CSCC) in a Real-World Setting”. SKIN The Journal of Cutaneous Medicine, vol. 7, no. 2, Mar. 2023, p. s174, https://doi.org/10.25251/skin.7.supp.174.